Abstract
Acute kidney injury (AKI) is a common early complication in patients with hematopoietic SCT (HSCT). However, there are limited data about the incidence and risk factors of AKI in patients with nonmyeloablative HSCT. We conducted a multicenter, retrospective cohort study of 62 patients from three institutions who were treated with similar protocols for nonmyeloablative HSCT. AKI was classified according to the Acute Kidney Injury Network criteria. It was shown that 29% of the patients developed AKI in the first 100 days after nonmyeloablative HSCT. The risk factor at baseline for AKI was incomplete HLA-matched transplant (odds ratio (OR) 3.6; 95% confidence interval (CI) 1.1–13.0). Complications such as acute GVHD, veno-occlusive disease of liver and sepsis were also associated with the development of AKI (OR 12.1; 95% CI 2.4–62.4). AKI was significantly associated with mortality (OR=4.7; 95% CI 1.9–11.5). We concluded that AKI is a very common complication in patients with nonmyeloablative HSCT, which is associated with incomplete HLA-matched transplant and complications, and has an important impact on the patients’ first year of survival.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Baker KS, Wagner JE . Novel conditioning regimens and nonmyeloablative stem cell transplants. Curr Opin Pediatr 2002; 14: 17–22.
Champlin RE . Nonmyeloablative hematopoietic transplantation for treatment of malignant diseases. Curr Opin Organ Transplant 2002; 7: 275–278.
Parikh CR, Mcsweeney P, Schrier RW . Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant. Kidney Int 2005; 67: 1999–2005.
Hingorani SR, Guthrie K, Batchelder A, Schoch G, Aboulhosn N, Manchion J et al. Acute renal failure after myeloablative hematopoietic cell transplant: Incidence and risk factors. Kidney Int 2005; 67: 272–277.
Caliskan Y, Besisik SK, Sargin D, Ecder T . Early renal injury after myeloablative allogeneic and autologous hematopoietic cell transplantation. Bone Marrow Transplant 2006; 38: 141–147.
Kersting S, Koomans HA, Hene RJ, Verdonck LF . Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, riskfactors and survival. Bone Marrow Transplant 2007; 39: 359–365.
Kersting S, Dorp SV, Tbeobald M, Verdonck LF . Acute renal failure after nonmyeloablative stem cell transplantation in Adults. Biol Blood Marrow Transplant 2008; 14: 125–131.
Parikh CR, Sandmaier BM, Storb RF, Blume KG, Sahebi F, Maloney DG et al. Acute renal failure after nonmyeloablative hematopoietic cell transplantation. J Am Soc Nephrol 2004; 15: 1868–1876.
Parikh CR, Schrier RW, Storer B, Diaconescu R, Sorror ML, Maris MB et al. Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation. Am J Kidney Dis 2005; 45: 502–509.
Waikar SS, Liu KD, Chertow GM . The incidence and prognostic significance of acute kidney injury. Curr Opin Nephrol Hypertens 2007; 16: 227–236.
Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW . Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005; 16: 3365–3370.
Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004; 15: 1597–1605.
Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG et al., the Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31.
Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825–828.
McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255–267.
Manjunath G, Sarnak MJ, Levey AS . Prediction equations to estimate glomerular filteration rate: an update. Curr Opin Nephrol Hypertens 2001; 10: 785–792.
Liu H, Ding JH, Liu BC, Zhao G, Chen BA . Early renal injury after nonmyeloablative allogeneic peripheral blood stem cell transplantation in patients with chronic myelocytic leukemia. Am J Nephrol 2007; 27: 336–341.
Niederwieser D, Maris M, Shizuru JA, Petersdorf E, Hegenbart U, Sandmaier BM et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 2003; 101: 1620–1629.
McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390–3400.
Gottlieb SS, Abraham W, Butler J, Forman DE, Loh E, Massie BM et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 2002; 8: 136–141.
Rao PS . Nephrotic syndrome in patients with peripheral blood stem cell transplant. Am J Kidney Dis 2005; 45: 780–785.
Szydlo R, Goldman JM, Klein JP, Gale RP, Ash RC, Bach FH et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 1997; 15: 1767–1777.
Acknowledgements
We acknowledge the fact that this research was supported by a grant from Jiangsu Provincial Key Medical Talent (no. RC 2007072) to Professor Liu BiCheng as PI.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, H., Li, YF., Liu, BC. et al. A multicenter, retrospective study of acute kidney injury in adult patients with nonmyeloablative hematopoietic SCT. Bone Marrow Transplant 45, 153–158 (2010). https://doi.org/10.1038/bmt.2009.99
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2009.99
Keywords
This article is cited by
-
Significance of men’s health in long-term survivors of allogeneic stem cell transplantation
Bone Marrow Transplantation (2022)
-
Predicting the risk of acute kidney injury after hematopoietic stem cell transplantation: development of a new predictive nomogram
Scientific Reports (2022)
-
The use of low doses of methotrexate during peri-cell infusion period may be a risk factor for acute kidney injury in patients subjected to hematopoietic stem cell transplantation
Annals of Hematology (2020)
-
Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis
Bone Marrow Transplantation (2020)
-
Renal dysfunction within 90 days of FluBu4 predicts early and late mortality
Bone Marrow Transplantation (2019)